Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management

Blood Cancer J. 2024 Aug 12;14(1):136. doi: 10.1038/s41408-024-01119-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Disease Management
  • Female
  • Humans
  • Immunotherapy, Adoptive* / adverse effects
  • Infant
  • Lymphohistiocytosis, Hemophagocytic* / diagnosis
  • Lymphohistiocytosis, Hemophagocytic* / therapy
  • Male
  • Middle Aged
  • Receptors, Chimeric Antigen* / immunology
  • Treatment Outcome

Substances

  • Receptors, Chimeric Antigen